From 2022 to 2030, the global eubiotics market is expected to increase from USD 5.90 Billion to USD 10.10 Billion, with a CAGR of 7.43%.
The global eubiotics market size was worth around USD 5.90 Billion in 2021 and is projected to grow around USD 10.10 Billion by 2030, with a compounded annual growth rate (CAGR) of roughly 7.43% from 2022 to 2030. The report analyzes the global high-throughput screening market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the enterprise data management market.
Eubiotics are essential feed additives that are widely used to maintain and even enhance the digestive health of poultry, swine, livestock, and aquatic animals. They are extensively used as a natural digestive stimulant and are used as a great alternative to antibiotics in the feed. Animal eubiotics play a major role in providing necessary nutrient absorption, enhancing immunity, and increasing overall performance for livestock for the production of well-nourished animals. Besides, eubiotics maintain a healthy blend of microbiota such as fungi, protists, bacteria, and archaea in the gastrointestinal tract of animals.
Increase in demand for better feed quality, nutrition, and protein for animals drives the growth of the market
There has been a significant surge in the livestock population base, and hence the importance of providing better feed quality to animals has gained immense traction due to a gradual increase in the consumption of meat among people across the globe. Animal feed that contains better nutrition and proteins has a favorable impact on the gut health, immunity system, and overall performance of the animal. Besides, an increase in awareness about the application of various natural compounds of eubiotics rather than antibiotic growth promoters (AGPs) drive the growth of the global eubiotics market during the forecast period.
Imposition of stringent rules and regulations toward product approvals may restrict the growth of the market
Stringent rules and regulations are imposed by the government of various nations regarding the application and approval of various eubiotic products. This further results in trade complexities that may restrict the growth of the eubiotic industry during the forecast period. In addition, the extortionate cost of producing various eubiotic compounds may also obstruct the growth of the market. Furthermore, low awareness about the efficiency of the product among people and several complications in food production chains further impede the growth of the market during the forecast period.
Increase in investment and expenditure for research and development proficiencies offers remunerative opportunities for the growth of the market
There has been a remarkable increase in investment and expenditure for animal consumption and research development for maintaining their and people’s health leading to large-scale industrialization of the livestock industry. In countries, such as India, China, and Japan, animal husbandry has gained massive traction and has been revamped into a thoroughly diversified activity. This was done by effectively highlighting the scientific management of farm animals, which would save costs and enhance productivity. These factors are expected to create ample opportunities for the growth of the industry.
Growing cases of disease outbreaks in livestock can act as a major challenge to the growth of the market
Increase in the cases of diseases in livestock is not only a threat to the health of the animals but also to human health due to increased animal consumption among us. Livestock is susceptible to various diseases such as H5N1 avian influenza, Q fever, Bovine spongiform encephalopathy, Nipah Virus, and bovine tuberculosis. These outbreaks in livestock can have a negative impact on the animal population, resulting in the reduction of herd productivity. Thus, disease outbreaks in livestock can have an adverse impact on the global food supply and human health, and local and worldwide economies.
The global eubiotics market is segmented based on type, form, livestock, function, and region.
Based on type, the global market is bifurcated into probiotics, prebiotics, essential oils, organic acids, and others. The probiotics segment held the largest market share in 2021, holding nearly 40% of the global market share, and is further expected to grow at a promising CAGR during the forecast period. The main reason for the growth of this segment is the increase in awareness about the application of probiotics in animal feed among people. Probiotics are essentially used in animal feed due to a bunch of benefits it provides such as improved gut health, better productivity, necessary immunity development, and enhancement of overall performance in animals.
In addition, a remarkable surge in research and development activities to create innovative, effective products and the availability of a wide range of product offerings from eminent players in the market further drive the growth of the segment during the forecast period.
Based on form, the global market is segmented into solid and liquid. The solid form segment held the dominating market share in 2021, occupying about 60.12%, and is further expected to grow at a promising CAGR during the forecast period. Solid forms usually include beadlet, cross-linked beadlet, and flakes. The high market share of this segment is mainly attributed to the improved protection of solid form from intermittent exposure to light and sunlight. Besides, the effective use of beadlet technology aids in preserving the active ingredients from heat and mechanical stress so as to make them sturdier and absorbable in feed production for animals.
Report Attributes | Report Details |
---|---|
Report Name | Eubiotics Market Research Report |
Market Size in 2021 | USD 5.90 Billion |
Market Forecast in 2030 | USD 10.10 Billion |
Compound Annual Growth Rate | CAGR of 7.43% |
Number of Pages | 193 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other global players. |
Segments Covered | By Type, By Form, By Livestock, By Function, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2021 |
Historical Year | 2016 to 2020 |
Forecast Year | 2022 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Europe to hold lion’s share in the global industry
The Europe region held the largest global eubiotics market share in 2021, holding over 42% of the market share, and is further expected to grow exponentially at a significant CAGR during the forecast period. The major reason for the growth of the market in this region is that countries major European countries such as Italy, Germany, and France have witnessed a notable increase in the consumption of meat over the past couple of years. There has been an increase in the production of livestock in the region to meet the growing demand of the people as consumption of processed food in the form of meat is also on the rise, which drives the growth of the market in the region. Thus, more and more producers in the region are corroborating disease-free, superior animal products that bolster the growth of the market in the region during the forecast period.
The global eubiotics market is dominated by players such as
The global eubiotics market is segmented as follows:
By Type
By Form
By Livestock
By Function
By Region
FrequentlyAsked Questions
The major factors influencing the growth of the global eubiotics market include an increase in awareness about antibiotic alternatives, a surge in demand for better feed quality, nutrition & protein for animals, a rise in livestock population, and an increase in the consumption of meat among people across the globe.
According to the report, the global eubiotics market was worth around USD 5.90 Billion in 2021 and is projected to grow around USD 10.10 Billion by 2030, with a compounded annual growth rate (CAGR) of roughly 7.43% from 2022 to 2030.
The global eubiotics market is expected to be driven by the Europe region. The major reason for the growth of the market in this region is the increase in the production of livestock and the rise in meat consumption in countries like Germany, Italy, and France.
The major players in the global eubiotics market include DSM, Novozymes, Kemin Industries, Inc., Roquette Frères, FrieslandCampina, Neospark Drugs and Chemicals Private Limited, ASAHI GROUP HOLDINGS, Ltd., Lesaffre, MSPrebiotics Inc., ADM, Lallemand Inc., BEHN MEYER, NOVUS INTERNATIONAL, BENEO, Yara, Cargill, Incorporated, BASF SE, Chr. Hansen Holding A/S, and ADDCON GmbH among other global players.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed